FDA clears Arterys Oncology AI suite

By AuntMinnie.com staff writers

February 15, 2018 -- The U.S. Food and Drug Administration (FDA) has cleared imaging software developer Arterys' Oncology AI suite.

The software runs on Arterys' Medical Imaging Cloud AI (MICA) platform and helps clinicians measure and track tumors or potential cancers, according to the firm. Its initial deep-learning workflows are for liver MRI and CT scans and lung CT.

Going forward, Arterys plans to develop additional deep-learning tools for the software for solid tumors in other organs, the company said.

Copyright © 2018 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking